Dow Up 0.51% Nasdaq Up 0.24%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
8.88 Down 0.10(1.11%) Nov 21, 4:00PM EST
Prev Close:8.98
Open:9.09
Bid:N/A
Ask:10.00 x 1500
1y Target Est:12.25
Beta:1.49
Next Earnings Date:N/A
Day's Range:8.85 - 9.10
52wk Range:6.52 - 11.47
Volume:431,170
Avg Vol (3m):393,337
Market Cap:381.22M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SUPN

Comparison

Symbol% ChgMkt Cap
SUPNDown 1.11%381.22M
JNJUp 0.35%301.91B

Key Statistics

Forward P/E (1 yr):20.65
P/S (ttm):3.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.01
Quarterly EPS Est (Dec-14) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback